Medtronic still seems confident about its renal denervation opportunity, but investors have "mostly given up," a medtech analyst observes.
FDA’s clearances are for artificial intelligence (AI) algorithms that detect leading indicators of heart disease.
King was once the San Francisco-based company’s president and CEO. He had served on the company’s board since July 2012.
After recalling the HawkOne Directional Atherectomy System earlier this year, Medtronic is also recalling (correcting) its TurboHawk Plus Directional Atherectomy System due to design similarities with the HawkOne.
A vascular surgeon needed a better way to make patients’ veins bigger to prepare them for dialysis. So he invented one.
The Redwood City, CA-based company said it has appointed John Farquhar as its president and CEO.
The company presented the data at the Cardiovascular Research Technologies annual conference.
The Salt Lake City, UT-based company is one-step closer to moving toward first-in-human trials for its Tria TAVR valve.
Quickly catch up on the latest medtech news from Medtronic, Abbott, Beta Bionics, and others.